Involvement of p21^Waf1/Cip1 in Protein Kinase C Alpha-Induced Cell Cycle Progression

REFERENCES

• Ahmad, S., Mineta, T., Martuza, R. L., and Glazer, R. I.. 1994. Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery 35:904–909
   PubMed Web of Science ®Google Scholar
• Arita, Y., Buffolino, P., and Coppock, D. L.. 1998. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Exp. Cell Res. 242:381–390
   PubMedGoogle Scholar
• Baltuch, G. H., Shenouda, G., Langleben, A., and Villemure, J. H.. 1993. High dose tamoxifen in the treatment of recurrent high-grade glioma: a report of clinical stabilization and tumor regression. Can. J. Neurol. Sci. 20:168–170
   PubMedGoogle Scholar
• Baltuch, G. H., Dooley, N. P., Couldwell, W. T., and Yong, V. W.. 1993. Staurosporine differentially inhibits glioma versus non-glioma cell lines. J. Neurooncol. 16:141–147
   PubMedGoogle Scholar
• Baltuch, G. H., Dooley, N. P., Villemure, J.-G., and Yong, V. W.. 1995. Protein kinase C and growth regulation of malignant gliomas. Can. J. Neurol. Sci. 22:264–271
   PubMedGoogle Scholar
• Begemann, M., Kashimawo, S. A., Choi, Y. J. A. et al. 1996. Inhibition of the growth of glioblastomas by CPG41251, an inhibitor of protein kinase C, and by phorbol ester tumor promoter. Clin. Cancer Res. 2:1017–1030
   PubMedGoogle Scholar
• Burns, K. L., Ueki, K., Jhung, S. L., Koh, J., and Louis, D. N.. 1998. Molecular genetics correlates of p16, CDK4, and Rb immunochemistry in glioblastomas. J. Neuropathol. Exp. Neurol. 57:122–130
   PubMed Web of Science ®Google Scholar
• Cheng, M., Olivier, P., Dielh, J. A., Fero, M., Roussel, M. F., Roberts, J. M., and Sherr, C. J.. 1999. The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583
   PubMed Web of Science ®Google Scholar
• Costello, J. F., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Huang, H. J. S., and Cavenee, W. K.. 1997. Cyclin dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57:1250–1254
   PubMed Web of Science ®Google Scholar
• Couldwell, W. T., Antel, J. P., and Yong, V. W.. 1992. Protein kinase C activity correlates with the growth rate of malignant gliomas. II. Effect of glioma mitogens and modulators of PKC. Neurosurgery 31:717–724
   PubMedGoogle Scholar
• Couldwell, W. T., Hinton, D. R., Surnock, A. A., DeGiorgio, C. M., Weiner, L. P., Apuzzo, M. L. J., Masri, L., and Weiss, M. H.. 1996. Treatment of recurrent malignant gliomas with chronic oral high dose tamoxifen. Clin. Cancer Res. 2:619–622
   PubMed Web of Science ®Google Scholar
• Dean, N., McKay, R., Miraglia, L., Howard, R., Cooper, S., Giddings, J., Nicklin, P., Meister, L., Ziel, R., Geiger, T., Muller, M., and Fabbro, D.. 1996. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C alpha expression. Cancer Res. 56:3499–3507
   PubMed Web of Science ®Google Scholar
• Delphin, C., and Baudier, J.. 1994. The protein kinase C activator, phorbol ester, cooperates with wild type p53 species in ras transformed embryo fibroblasts growth arrest. J. Biol. Chem. 269:29579–29587
   PubMedGoogle Scholar
• Dirks, P. B., Hubbard, S. L., Murakami, M., and Rutka, J. T.. 1997. Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J. Neuropathol. Exp. Neurol. 56:291–300
   PubMed Web of Science ®Google Scholar
• Estanyol, J. M., Jaumont, M., Casanovas, O., Rodriguez-Vilarrupla, A., Agell, N., and Bachs, O.. 1999. The protein SET regulates the inhibitory effect of p21/Cip1 on cyclin-E-cyclin dependent kinase-2 activity. J. Biol. Chem. 274:33161–33165
   PubMed Web of Science ®Google Scholar
• Fishman, D. D., Segal, S., and Livneh, E.. 1998. The role of protein kinase C in G1 and G2/M phases of the cell cycle. Int. J. Oncol. 12:181–186
   PubMed Web of Science ®Google Scholar
• Frey, M. R., Saxon, M. L., Zhao, X., Rollins, A., Evans, S. S., and Black, J. D.. 1997. Protein kinase C mediated cell cycle arrest involves induction of p21Waf1/Cip1 and p27Kip1 and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J. Biol. Chem. 272:9424–9435
   PubMed Web of Science ®Google Scholar
• Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., and Galloway, D. A.. 1997. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:2090–2100
   PubMed Web of Science ®Google Scholar
• Hamada, K., Takuwa, N., Zhou, W., Kumada, M., and Takuwa, Y.. 1993. Protein kinase C inhibits the CAK-CDK2 cyclin dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochim. Biophys. Acta 1310:149–156
   Google Scholar
• Hass, R., Gunji, H., Hirano, M., Weichselbaum, R., and Kufe, D.. 1993. Phorbol ester induced monocytic differentiation is associated with G2 delay and down regulation of cdc25 expression. Cell Growth Differ. 4:159–166
   PubMedGoogle Scholar
• He, J., Olson, J. J., and James, C. D.. 1995. Lack of p16INK4 or retinoblastoma protein (Rb), or amplification associated overexpression of CDK4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55:4833–4836
   PubMed Web of Science ®Google Scholar
• Herman, J. G., Jen, J., Merlo, A., and Baylin, S. B.. 1996. Hypermethylation associated inactivation indicates a tumor suppressor role for p15/INK4b1. Cancer Res. 56:722–727
   PubMed Web of Science ®Google Scholar
• Hiyama, H., Iavarone, A., and Reeves, S. A.. 1998. Regulation of the CDK inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16:1513–1523
   PubMedGoogle Scholar
• Jaken, S.. 1996. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8:168–173
   PubMed Web of Science ®Google Scholar
• Jones, D. L., Alani, R. M., and Munger, K.. 1997. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11:2101–2111
   PubMed Web of Science ®Google Scholar
• Jung, J. M., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, T., Levin, V. A., and Zhang, W.. 1995b. Increased levels of p21/Waf1/Cip1 in human brain tumors. Oncogene 11:2021–2028
   PubMed Web of Science ®Google Scholar
• Kazanietz, M. G., Areces, L. B., Bahador, A., Mischak, H., Goodnight, J., Mushinski, J. F., and Blumberg, P. M.. 1993. Characterization of ligand and substrate specificity for the calcium-dependent and calcium independent protein kinase C isozymes. Mol. Pharmacol. 44:298–307
   PubMed Web of Science ®Google Scholar
• Korkolopoulou, P., Kouzelis, K., Christodoulou, P., Papanikolaou, A., and Thomas-Tsagli, E.. 1998. Expression of retinoblastoma gene product and p21/Waf1/Cip1 protein in gliomas: correlations with proliferation markers, p53 expression and survival. Acta Neuropathol. 95:617–624
   PubMedGoogle Scholar
• Kosaka, C., Sasaguri, T., Ishida, A., and Ogata, J.. 1996. Cell cycle arrest in G2 phase induced by phorbol ester and diacylglycerol in vascular endothelial cells. Am. J. Physiol. 270:C170–C178
   PubMedGoogle Scholar
• LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E.. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847–862
   PubMed Web of Science ®Google Scholar
• Li, S., MacLachlan, T. K., De Luca, A., Claudio, P. P., Condorelli, G., and Giordano, A.. 1995. The cdc-2 related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle. Cancer Res. 55:3992–3995
   PubMedGoogle Scholar
• Livneh, E., Shimon, T., Bechor, E., Doki, Y., Schieren, I., and Weinstein, I. B.. 1996. Linking protein kinase C to the cell cycle: ectopic expression of PKC eta in NIH-3T3 cells alters the expression of cyclins and CDK inhibitors and induces adipogenesis. Oncogene 12:1545–1555
   PubMed Web of Science ®Google Scholar
• Livneh, E., and Fishman, D. D.. 1997. Linking protein kinase C to cell cycle control. Eur. J. Biochem. 248:1–9
   PubMedGoogle Scholar
• Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T.. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935–944
   PubMed Web of Science ®Google Scholar
• Mann, D. J., Higgins, T., Jones, N. C., and Rozengurt, E.. 1997. Differential control of cyclins D1 and D3 and the CDK inhibitor p27/Kip1 by diverse signaling pathways in Swiss 3T3 cells. Oncogene 14:1759–1766
   PubMedGoogle Scholar
• Mantel, C., Luo, Z., Canfield, J., Braun, S., Deng, C., and Broxmeyer, H. E.. 1996. Involvement of p21Cip1 and p27Kip1 in the molecular mechanisms of Steel Factor induced proliferative synergy in vitro and of p21Cip1 in the maintenance of stem/progenitor cells in vivo. Blood 88:3710–3719
   PubMedGoogle Scholar
• Mastronardi, L., Puzzilli, F., Couldwell, W. T., Farah, J. O., and Lunardi, P.. 1998. Tamoxifen and carboplatin combinational treatment of high-grade gliomas. J. Neurooncol. 38:59–68
   PubMedGoogle Scholar
• Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J.-Y.. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076
   PubMed Web of Science ®Google Scholar
• Mellor, H., and Parker, P. J.. 1998. The extended protein kinase C superfamily. Biochem. J. 332:281–292
   PubMed Web of Science ®Google Scholar
• Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D.. 1994. Induction of WAF1/CIP1 by a p53 independent pathway. Cancer Res. 54:3391–3395
   PubMed Web of Science ®Google Scholar
• Newton, A. C.. 1997. Regulation of protein kinase C. Curr. Opin. Cell Biol. 9:161–167
   PubMed Web of Science ®Google Scholar
• Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., and Roberts, J. M.. 1994. Interleukin-2 mediated elimination of the p27Kip1 cyclin dependent kinase inhibitor prevented by rapamycin. Nature 372:570–573
   PubMed Web of Science ®Google Scholar
• Pollack, I. F., and Kawecki, S.. 1997. The effect of Calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro. J. Neurooncol. 31:255–266
   PubMedGoogle Scholar
• Ryves, W. J., Evans, A. T., Olivier, A. R., Parker, P. J., and Evans, F. J.. 1991. Activation of the PKC isotypes alpha, beta 1, gamma, delta, and epsilon by phorbol esters of different biological activities. FEBS Lett. 288:5–9
   PubMed Web of Science ®Google Scholar
• Sioud, M., and Sorensen, D. R.. 1998. A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth. Nat. Biotechnol. 16:556–561
   PubMed Web of Science ®Google Scholar
• Sonoda, Y., Yoshimoto, T., and Sekiya, T.. 1995. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 11:2145–2149
   PubMed Web of Science ®Google Scholar
• Srivenugopal, K. S., and Ali-Osman, F.. 1996. Deletions and rearrangements inactivate the p16/INK4 gene in human glioma cells. Oncogene 12:2029–2034
   PubMedGoogle Scholar
• Thompson, L. J., and Fields, A. P.. 1996. Beta2 protein kinase C is required for the G2/M transition of cell cycle. J. Biol. Chem. 271:15045–15053
   PubMedGoogle Scholar
• Yazaki, T., Ahmad, S., Chablavi, A., Zylber-Katz, E., Dean, N. M., Rabkin, S. D., Martuza, R. L., and Glazer, R. I.. 1996. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide. Mol. Pharmacol. 50:236–242
   PubMed Web of Science ®Google Scholar
• Yong, V. W., Dooley, N. P., and Noble, P. G.. 1994. Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform alpha as a mediator of process outgrowth. J. Neurosci. Res. 39:83–96
   PubMed Web of Science ®Google Scholar
• Zeng, Y.-X., and El-Deiry, W. S.. 1996. Regulation of p21/Waf1/Cip1 expression by p53 independent mechanisms. Oncogene 12:1557–1564
   PubMed Web of Science ®Google Scholar
• Zezula, J., Sexl, V., Hutter, C., Karel, A., Schutz, W., and Freissmuth, M.. 1997. The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J. Biol. Chem. 272:29967–29974
   PubMedGoogle Scholar
• Zhang, H., Hannon, G. H., and Beach, D.. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750–1758
   PubMed Web of Science ®Google Scholar